Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gregson

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
The Canadian Journal of Cardiology|August 13, 2023
Nonproportional Hazards Demystified: Why They Matter for Planning and Interpreting Clinical TrialsJohn Gregson, Stuart Pocock
Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'Enfant Et De L'Adolescent|June 3, 2008
A context for classification in child psychiatryNormand Carrey, John Gregson
European Heart Journal|January 29, 2019
Raised blood pressure and risk of dementiaJohn Gregson, Nawab Qizilbash, Stuart Pocock
The Lancet. Diabetes & Endocrinology|July 4, 2015
Does midlife obesity really lower dementia risk? - Authors' replyNawab Qizilbash, John Gregson, Stuart Pocock
JACC. Heart Failure|April 28, 2022
Covariate Adjustment in Cardiovascular Randomized Controlled Trials: Its Value, Current Practice, and Need for ImprovementLeah Pirondini, John Gregson, Ruth Owen, et al.
Atherosclerosis|July 13, 2012
Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literatureJohn Gregson, Heide A Stirnadel-Farrant, Indraraj Umesh Doobaree, et al.
NEJM Evidence|February 24, 2026
Evaluating Noninferiority in Clinical Trials with a Hierarchical End PointJohn Gregson, Bjorn Redfors, David J Cohen, et al.
Clinical Cardiology|April 6, 2021
Blood pressure reduction and anti-hypertensive treatment choice: A post-hoc analysis of the SPRINT trialJoão Pedro Ferreira, John Gregson, Michael Böhm, et al.
Journal of the American College of Cardiology|October 19, 2019
Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials: JACC Review Topic of the WeekJohn Gregson, Linda Sharples, Gregg W Stone, et al.
Neuroepidemiology|October 19, 2012
Patent foramen ovale, ischemic stroke and migraine: systematic review and stratified meta-analysis of association studiesDaniel Davis, John Gregson, Peter Willeit, et al.
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
The Canadian Journal of Cardiology|August 13, 2023
Nonproportional Hazards Demystified: Why They Matter for Planning and Interpreting Clinical TrialsJohn Gregson, Stuart Pocock
Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal De L'Academie Canadienne De Psychiatrie De L'Enfant Et De L'Adolescent|June 3, 2008
A context for classification in child psychiatryNormand Carrey, John Gregson
European Heart Journal|January 29, 2019
Raised blood pressure and risk of dementiaJohn Gregson, Nawab Qizilbash, Stuart Pocock
The Lancet. Diabetes & Endocrinology|July 4, 2015
Does midlife obesity really lower dementia risk? - Authors' replyNawab Qizilbash, John Gregson, Stuart Pocock
JACC. Heart Failure|April 28, 2022
Covariate Adjustment in Cardiovascular Randomized Controlled Trials: Its Value, Current Practice, and Need for ImprovementLeah Pirondini, John Gregson, Ruth Owen, et al.
Atherosclerosis|July 13, 2012
Variation of lipoprotein associated phospholipase A2 across demographic characteristics and cardiovascular risk factors: a systematic review of the literatureJohn Gregson, Heide A Stirnadel-Farrant, Indraraj Umesh Doobaree, et al.
NEJM Evidence|February 24, 2026
Evaluating Noninferiority in Clinical Trials with a Hierarchical End PointJohn Gregson, Bjorn Redfors, David J Cohen, et al.
Clinical Cardiology|April 6, 2021
Blood pressure reduction and anti-hypertensive treatment choice: A post-hoc analysis of the SPRINT trialJoão Pedro Ferreira, John Gregson, Michael Böhm, et al.
Journal of the American College of Cardiology|October 19, 2019
Nonproportional Hazards for Time-to-Event Outcomes in Clinical Trials: JACC Review Topic of the WeekJohn Gregson, Linda Sharples, Gregg W Stone, et al.
Neuroepidemiology|October 19, 2012
Patent foramen ovale, ischemic stroke and migraine: systematic review and stratified meta-analysis of association studiesDaniel Davis, John Gregson, Peter Willeit, et al.
Pageof 12